Sulfapyridine → 4-[[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]amino]-N-pyridin-2-ylbenzenesulfonamide
Reaktionsgleichung
O[CH:2]=[C:3]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[NH:5][C:4]1=[O:12].[CH:13]1[CH:14]=[CH:15][N:16]=[C:17]([NH:19][S:20]([C:23]2[CH:24]=[CH:25][C:26]([NH2:29])=[CH:27][CH:28]=2)(=[O:22])=[O:21])[CH:18]=1>>[O:12]=[C:4]1[NH:5][C:6]2[C:11](/[C:3]/1=[CH:2]/[NH:29][C:26]1[CH:25]=[CH:24][C:23]([S:20]([NH:19][C:17]3[CH:18]=[CH:13][CH:14]=[CH:15][N:16]=3)(=[O:22])=[O:21])=[CH:28][CH:27]=1)=[CH:10][CH:9]=[CH:8][CH:7]=2Komponenten
3
Versuchsvorschrift
The title compound was prepared analogous to Example 5 from 3-(hydroxymethylene)-1,3-dihydro-2H-indol-2-one and sulfapyridine. Electrospray MS 393 (MH+).
Quellen und Nachweise
- ORD-Eintrag
- ord-79944e9e44d241d6b9eda7d2246fbae6
- Quelldatensatz
- uspto-grants-2008_03
- Patentnummer
- US07338966B2